EpilepsyGTx, a biotechnology company developing cutting-edge gene therapies to treat refractory epilepsy, and ClearPoint Neuro ("ClearPoint"), a global therapy-enabling company offering precise ...
In a first-of-its-kind clinical trial, U.S. researchers have found that people with agitation and dementia in late life who took a special medical formulation of two active ingredients found in ...
Women who are civically engaged are more likely to undergo routine breast cancer screening than those who are less active in their communities, cross-sectional study results suggest.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results